VeriDoc Ledger
Pharmaceuticals
Insulin
Medicines are among the most counterfeited products globally, putting patient safety at significant risk. VeriDoc Global can secure pharmaceutical products, such as Insulin, with a blockchain verified QR code to help customers confirm authenticity, batch details, and check for any ongoing product recalls.
Explore the complete proof of concept and see the technology come to life.
Why Insulin Authentication is Critical for Patient Safety
How Insulin Verification Works
with VeriDoc Global
Key Features That Ensure Insulin Product Authenticity
Batch Number
Verify the unique batch number assigned to the insulin at the time of manufacturing. This ensures the product is linked to its original production batch. Any mismatch in batch data is immediately detected during verification.
Product Type
Confirm the insulin type or product name recorded at issuance. This ensures the medication matches the intended formulation and classification. Any inconsistency in product identity is clearly identified.
Expiry Date
Validate the expiry date captured during manufacturing. This ensures the insulin is within its safe usage period. Any alteration in expiry data is instantly flagged during verification.
How VeriDoc Global Secures Insulin Products with Trusted Verification Technology
VeriDoc Global secures insulin products by combining advanced cryptographic hashing with the VeriDoc Ledger to create a reliable and tamper-proof verification system. Key data such as batch number, product type, dosage information, manufacturing details, and expiry date are captured and converted into a secure digital fingerprint.
This fingerprint is stored immutably on the VeriDoc Ledger, ensuring that the original insulin product data cannot be altered, deleted, or replaced. The QR code attached to the product provides instant access to its verification layer without exposing sensitive pharmaceutical information.
When scanned, the system compares the live product data with the stored hash and delivers an immediate authentication result. This eliminates manual validation and significantly reduces the risk of counterfeit or unsafe insulin entering the supply chain.
For manufacturers, healthcare providers, pharmacies, and patients, this creates a secure and transparent system where insulin products can be trusted, verified instantly, and confidently used. VeriDoc Global transforms critical pharmaceutical products into verifiable, tamper-proof assets that support patient safety and treatment reliability.
